TapewireFind a company

person · Reporting owner

AUGUSTINOS NICHOLAS

Disclosed activity across 1 company

Tapewire entity
23809
SEC CIK
0001238485

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DEXCOM INCDXCM · Entity 3114DirectorSeptember 14, 2026September 16, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DEXCOM INC

Report date September 14, 2026 · Filed September 16, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectby Trust29,293 Last balance in matching sequence After 2026-09-15 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2026-09-14 · Sale · Disposed 1,550 · Balance 35,832

F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

Row 2 · 2026-09-15 · Sale · Disposed 6,539 · Balance 29,293

F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

Common StockSEC Table I · non-derivativeDirect5,575 Reported balance Holding disclosure · report date 2026-09-14 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 5,575

F3: Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

F3: Represents unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 15, 2026 Filed Sep 16, 2026 20:26 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 6,539 $84.04 $549,537.56
Disclosure

SEC source: 0001093557-26-000179 · wk-form4_1789590361.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust

Disclosed balance after: 29,293

F1 · shares: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

Read SEC document
September 14, 2026 Filed Sep 16, 2026 20:26 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,550 $84.02 $130,231.00
Disclosure

SEC source: 0001093557-26-000179 · wk-form4_1789590361.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust

Disclosed balance after: 35,832

F1 · shares: On June 10, 2026, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

Read SEC document
August 12, 2026 Filed Aug 13, 2026 22:38 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 1,075 $0.00 $0.00
Disclosure

SEC source: 0001093557-26-000147 · wk-form4_1786660703.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 37,382

F1 · kind: Represents a donation of shares to a charitable donor advised fund.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the Reporting Person is a trustee.

Read SEC document
May 28, 2026 Filed Jun 1, 2026 21:34 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 5,575 $0.00 $0.00
Disclosure

SEC source: 0001093557-26-000123 · wk-form4_1780349697.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,575

F1 · shares: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

Read SEC document
May 08, 2026 Filed May 11, 2026 23:13 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 5,046 $0.00 $0.00
Disclosure

SEC source: 0001093557-26-000081 · wk-form4_1778541197.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 38,457

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee.

Read SEC document
May 08, 2026 Filed May 11, 2026 23:13 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 5,046 $0.00 $0.00
Disclosure

SEC source: 0001093557-26-000081 · wk-form4_1778541197.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 21:33 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 3,672 $82.80 $304,041.60
Disclosure

SEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust

Disclosed balance after: 33,411

F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 21:33 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 2,618 $81.69 $213,864.42
Disclosure

SEC source: 0001093557-25-000212 · wk-form4_1750195990.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust

Disclosed balance after: 37,083

F1 · shares: On March 14, 2025, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is a trustee.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:08 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 5,046 $0.00 $0.00
Disclosure

SEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,046

F3 · shares: The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:08 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 2,618 $0.00 $0.00
Disclosure

SEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 39,701

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, with respect to which the reporting person is trustee.

Read SEC document
May 08, 2025 Filed May 12, 2025 20:08 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 2,618 $0.00 $0.00
Disclosure

SEC source: 0001093557-25-000150 · wk-form4_1747080485.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:39 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 2,618 $0.00 $0.00
Disclosure

SEC source: 0001093557-24-000112 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,618

F1 · shares: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

Read SEC document
May 18, 2024 Filed May 21, 2024 20:07 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 3,043 $0.00 $0.00
Disclosure

SEC source: 0001093557-24-000092 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 37,083

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F2 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 18, 2024 Filed May 21, 2024 20:07 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 3,043 $0.00 $0.00
Disclosure

SEC source: 0001093557-24-000092 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

Read SEC document
December 15, 2023 Filed Dec 18, 2023 21:32 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 3,976 $123.02 $489,127.52
Disclosure

SEC source: 0001093557-23-000246 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · by Trust

Disclosed balance after: 34,040

F1 · shares: On September 15, 2023, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 18, 2023 Filed May 22, 2023 19:49 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 3,976 $0.00 $0.00
Disclosure

SEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 38,016

F2 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F3 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 18, 2023 Filed May 22, 2023 19:49 UTC DEXCOM INC DXCM · Entity 3114 GiftCommon Stock 3,976 $0.00 $0.00
Disclosure

SEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,043

F2 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

Read SEC document
May 18, 2023 Filed May 22, 2023 19:49 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 3,043 $0.00 $3.04
Disclosure

SEC source: 0001093557-23-000141 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,019

F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

Read SEC document
May 20, 2022 Filed May 23, 2022 21:04 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 994 $0.00 $0.99
Disclosure

SEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 994

F2 · shares: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F3 · balance_after: Represents 994 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting.

Read SEC document
May 19, 2022 Filed May 23, 2022 21:04 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 918 $0.00 $0.00
Disclosure

SEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 8,510

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F4 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 19, 2022 Filed May 23, 2022 21:04 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 918 $0.00 $0.00
Disclosure

SEC source: 0001093557-22-000114 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

Read SEC document
October 29, 2021 Filed Nov 2, 2021 21:12 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 2,500 $600.03 $1,500,086.75
Disclosure

SEC source: 0001093557-21-000252 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 918

F1 · shares: On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $600.00 to $600.295. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.

Read SEC document
June 03, 2021 Filed Jun 7, 2021 23:35 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 806 $366.99 $295,793.94
Disclosure

SEC source: 0001093557-21-000165 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,110

F1 · shares: On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.

Read SEC document
May 21, 2021 Filed May 25, 2021 23:15 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 918 $0.00 $0.92
Disclosure

SEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,916

F3 · shares: The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F4 · balance_after: Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.

Read SEC document
March 18, 2021 Filed May 25, 2021 23:15 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 2,192 $0.00 $0.00
Disclosure

SEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 7,900

F1 · shares: Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership.

F5 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
March 18, 2021 Filed May 25, 2021 23:15 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 2,192 $0.00 $0.00
Disclosure

SEC source: 0001093557-21-000135 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,998

F1 · shares: Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership.

F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 02:36 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,875 $412.03 $772,556.25
Disclosure

SEC source: 0001093557-21-000026 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 10,092

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
January 06, 2021 Filed Jan 7, 2021 21:40 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 625 $375.00 $234,375.00
Disclosure

SEC source: 0001093557-21-000004 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 11,967

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
December 16, 2020 Filed Dec 19, 2020 00:53 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 625 $356.82 $223,012.50
Disclosure

SEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 12,592

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
December 16, 2020 Filed Dec 19, 2020 00:53 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 25 $354.00 $8,850.00
Disclosure

SEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,217

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
December 16, 2020 Filed Dec 19, 2020 00:53 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 600 $352.20 $211,320.00
Disclosure

SEC source: 0001093557-20-000327 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,242

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 20:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 126 $402.49 $50,713.87
Disclosure

SEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 5

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,842

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F7 · price: This transaction was executed in multiple trades at prices ranging from $402.07 to $402.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 20:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 88 $400.94 $35,282.80
Disclosure

SEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 4

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 13,968

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $400.80 to $401.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 20:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,471 $399.84 $588,157.87
Disclosure

SEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 14,056

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $399.45 to $400.41. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 20:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 66 $398.11 $26,274.93
Disclosure

SEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 15,527

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $398.06 to $398.33. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
September 16, 2020 Filed Sep 18, 2020 20:57 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 124 $396.51 $49,166.69
Disclosure

SEC source: 0001093557-20-000266 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 15,593

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $396.11 to $397.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 22:01 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 625 $375.00 $234,375.00
Disclosure

SEC source: 0001093557-20-000192 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 15,717

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 22:01 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,250 $362.47 $453,087.50
Disclosure

SEC source: 0001093557-20-000192 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 16,342

F1 · shares: On March 4, 2020, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 22, 2020 Filed May 27, 2020 21:11 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 806 $0.00 $0.81
Disclosure

SEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 806

F3 · shares: The RSU Award was granted on May 22, 2020 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting.

Read SEC document
May 21, 2020 Filed May 27, 2020 21:11 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 3,230 $0.00 $0.00
Disclosure

SEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 17,592

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F4 · balance_after: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

F4 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
May 21, 2020 Filed May 27, 2020 21:11 UTC DEXCOM INC DXCM · Entity 3114 OtherCommon Stock 3,230 $0.00 $0.00
Disclosure

SEC source: 0001093557-20-000154 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F2 · balance_after: Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting.

Read SEC document
February 14, 2020 Filed Feb 18, 2020 23:58 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,812 $283.80 $514,245.60
Disclosure

SEC source: 0001093557-20-000031 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,230

F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
December 16, 2019 Filed Dec 17, 2019 02:17 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,812 $206.14 $373,525.68
Disclosure

SEC source: 0001093557-19-000259 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,042

F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
November 07, 2019 Filed Nov 9, 2019 01:58 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,208 $185.29 $223,830.32
Disclosure

SEC source: 0001093557-19-000241 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,854

F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
September 16, 2019 Filed Sep 18, 2019 22:03 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,208 $145.49 $175,751.92
Disclosure

SEC source: 0001093557-19-000213 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,062

F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
June 14, 2019 Filed Jun 17, 2019 21:50 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 1,208 $146.32 $176,754.56
Disclosure

SEC source: 0001093557-19-000163 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,270

F1 · shares: On March 1, 2019, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
May 31, 2019 Filed Jun 4, 2019 23:57 UTC DEXCOM INC DXCM · Entity 3114 GrantCommon Stock 2,676 $0.00 $2.68
Disclosure

SEC source: 0001093557-19-000149 · wf-form4_155969260951522.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,478

F1 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting.

Read SEC document
August 06, 2018 Filed Aug 9, 2018 00:33 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 3,230 $121.77 $393,300.95
Disclosure

SEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 3

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 14,362

F4 · ownership.nature: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.

Read SEC document
August 06, 2018 Filed Aug 9, 2018 00:33 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 2,970 $121.72 $361,511.37
Disclosure

SEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 2

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,802

F3 · price: This transaction was executed in multiple trades at prices ranging from $121.39 to $122.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 3,449 restricted stock units which were granted on June 1, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.

Read SEC document
August 06, 2018 Filed Aug 9, 2018 00:33 UTC DEXCOM INC DXCM · Entity 3114 SaleCommon Stock 6,100 $120.91 $737,568.69
Disclosure

SEC source: 0001093557-18-000163 · edgardoc.xml · nonDerivative · entry 1

AUGUSTINOS NICHOLAS · CIK 0001238485 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,772

F1 · price: This transaction was executed in multiple trades at prices ranging from $120.37 to $121.32. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2 · balance_after: Included in this number are 3,449 restricted stock units which were granted on June 1, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.